US Corporate Distress Financial Stress SEC Filings — May 18, 2026

18-05-2026

FOXO TECHNOLOGIES INC. filed an 8-K on May K on May 18, 2026, disclosing Item 1.01 (Entry into a Material Definitive Agreement) and Item 9.01 (Financial Statements and Exhibits). No specific terms, dollar amounts, or strategic details are provided in the summary, making it impossible to assess materiality or directional impact. The filing is multi item but lacks quantitative disclosure.

• · Filing date: May 18, 2026
• · Company: FOXO TECHNOLOGIES INC.
• · 8 K Items: 1.01 and 9.01
• · Size: 9 MB (indicates exhibits likely attached)
• · No dollar amounts, share counts, or percentage changes disclosed in the summary.

18-05-2026

NEXTERA ENERGY INC filed an 8-K on May 18, 2026, disclosing Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). The filing size is 11 MB, indicating substantive exhibit attachments, but the specific terms, counterparties, and financial details of the agreement are not provided in the available metadata. Without the filing text, no performance metrics or directional changes can be assessed.

18-05-2026

Ideal Power announced a $30.0 million registered direct offering of 5,291,005 shares of common stock (or equivalents) priced at market under Nasdaq rules, expected to close on May 18, 2026. The company intends to use net proceeds to advance commercialization of its B-TRAN bidirectional semiconductor power switch, including customer design-ins, custom development programs, and initial production ramp with strategic partners. While the offering strengthens the balance sheet at a pivotal moment, it will dilute existing shareholders.

• · The offering is made pursuant to an effective shelf registration statement on Form S-3 (No. 333-292492) declared effective on January 9, 2026.
• · A prospectus supplement and accompanying prospectus will be filed with the SEC.
• · The sole placement agent is Titan Partners, a division of American Capital Partners.
• · CEO David Somo highlighted accelerating demand for data centers and power as a driver for the financing.
• · Proceeds will also be used for general corporate and working capital purposes.
• · The offering is priced at market under Nasdaq rules, not a fixed per-share price.

18-05-2026

ImmunityBio entered an exclusive U.S. Development and Supply Agreement with Japan BCG Laboratory for the Tokyo strain of BCG, aiming to address the chronic BCG shortage in the U.S. The agreement follows a positive Phase III readout (SWOG S1602) demonstrating non-inferior efficacy of the Tokyo strain versus TICE BCG in BCG-naïve high-grade NMIBC, with a hazard ratio of 0.82 (95.8% CI 0.63–1.08) against a non-inferiority margin of 1.34. ImmunityBio plans to engage the FDA to pursue U.S. approval and serve as the sole BLA applicant, while continuing its Expanded Access Program for recombinant BCG through its partnership with Serum Institute of India.

• · The Tokyo strain of BCG has been used in Japan for almost 30 years for high-risk NMIBC.
• · SWOG S1602 enrolled 1,000 patients (984 eligible) between February 2017 and December 2020, randomized 1:1:1 to TICE BCG (n=330), intravesical Tokyo-172 BCG (n=327), or intradermal priming + intravesical Tokyo-172 BCG (n=327).
• · Progression-free survival was similar across all arms.
• · The BCG shortage in the U.S. has persisted for over a decade.
• · ANKTIVA is FDA-approved in combination with BCG for BCG-unresponsive NMIBC with CIS; the Tokyo strain is investigational in the U.S.
• · The partnership gives ImmunityBio a second potential BCG source (the first being Serum Institute's rBCG).

18-05-2026

GMR Solutions Inc. entered into a Tax Receivable Agreement (TRA) on May 14, 2026, with KKR GMR Consolidated Aggregator LLC and other parties, effective upon the IPO closing date. The TRA provides for payments to TRA parties based on realized tax benefits from tax attributes and imputed interest, with payment mechanisms, subordination, and change-of-control provisions. No specific monetary amounts or financial impacts are disclosed in the filing excerpt.

• · The TRA defines 'Change of Control' events (e.g., acquisition of >50% voting power, merger, liquidation) that can trigger accelerated payment obligations.
• · The agreement includes a subordination clause (Article V) prioritizing payments under the TRA over certain other obligations.
• · Disputes under the TRA are to be resolved through an expert determination process (Section 7.9) or litigation in Delaware.
• · The TRA contains confidentiality provisions and a TRA Party Representative (KKR GMR Consolidated Aggregator LLC) to act on behalf of all TRA parties.

18-05-2026

Brand Engagement Network Inc. entered into a definitive Reseller Agreement with Accelevate Solutions on May 14, 2026, granting its subsidiary SKYE AI USA, LLC exclusive rights to the African continent for an initial five-year term, subject to annual renewal based on minimum revenue thresholds. The licensor will receive 35% of gross revenue (excluding hardware) from sales. While this expands the company's footprint in Africa, the revenue-sharing obligation and performance-based renewal introduce future financial commitments and uncertainties.

• · The agreement includes a joint Pricing Committee and standard indemnification and confidentiality provisions.
• · Exclusive rights are subject to annual renewal based on minimum revenue thresholds for subsequent consecutive years.
• · The Company previously disclosed a letter agreement with Accelevate on April 22, 2026, which led to this definitive agreement.
• · The Company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

18-05-2026

Bitcoin Depot Inc. filed an 8-K on May 18, 2026, reporting multiple material events including a bankruptcy or receivership (Item 1.03), triggering events that accelerate direct financial obligations (Item 2.04), and departure of directors or officers (Item 5.02). The filing indicates a severe financial distress leading to bankruptcy proceedings, but specific financial details, dollar amounts, and names are not disclosed in the provided summary.

• · Filing includes multiple 8-K items (1.03, 2.04, 5.02, 7.01, 9.01) indicating a comprehensive material event.
• · Exact dollar amounts, share counts, and specific executive names are NOT_DISCLOSED in the provided summary.
• · Sector not specified; Bitcoin Depot Inc. is a Bitcoin ATM operator (known from public information, but not in filing).

18-05-2026

LiveRamp reported Q4 FY26 revenue of $206M (+9% YoY) and FY26 revenue of $813M (+9% YoY), with record annual operating cash flow of $168M. However, Q4 operating cash flow declined to $59M from $63M in the prior year, and FY26 non-GAAP gross margin compressed by 1 percentage point to 73%. The company also announced a definitive agreement to be acquired by Publicis Groupe for $38.50 per share in an all-cash transaction valued at $2.5B equity, representing a 30% premium to the closing price on May 15, 2026.

• · Q4 FY26 GAAP diluted EPS was $1.12 (benefited from deferred tax valuation allowance release), non-GAAP diluted EPS $0.52.
• · FY26 GAAP diluted EPS $2.24, non-GAAP diluted EPS $2.27.
• · Subscription net retention improved to 107% in Q4; platform net retention was 108%.
• · Q4 FY26 share repurchases totaled 2.8 million shares for $76M; FY26 total 7.1 million shares for $194M.
• · Remaining share repurchase authorization of $262M as of March 31, 2026, expiring December 31, 2027.
• · Appointed Kristi Argyilan to the Board of Directors on February 11, 2026.
• · LiveRamp will not host earnings conference call due to pending acquisition.
• · Transaction expected to close by end of calendar 2026, subject to shareholder approval and customary conditions.
• · Q4 FY26 GAAP operating margin of 7% expanded 14 percentage points YoY; non-GAAP operating margin 20% expanded 7 points.
• · FY26 GAAP operating margin 10% expanded 10 points; non-GAAP 22% expanded 4 points.
• · FY26 GAAP gross margin flat at 71%; non-GAAP gross margin compressed 1 point to 73%.

18-05-2026

Perma-Fix Environmental Services announced an underwritten public offering of common stock to fund capacity upgrades at its Northwest Richland facility, continued development of its patent-pending Perma-FAS technology for PFAS destruction, and general corporate purposes. Craig-Hallum is acting as sole managing underwriter. The offering is subject to market conditions, with no assurance of completion or final terms.

• · The offering is made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-283555) declared effective on December 12, 2024.
• · The preliminary prospectus supplement and accompanying prospectus will be filed with the SEC and available on the SEC's website or from Craig-Hallum.

18-05-2026

Faraday Future announced $25M in new convertible note financing, bringing total financing to $70M over two months (including $45M from April), sufficient to support Phase 1 of its EAI robotics strategy by end of 2026. The company raised its full-year shipment target to 1,500 units and declared a shift from liquidity-driven to capital-structure-driven financing. However, only $12.5M is immediately available to the operating account; the remainder is in controlled accounts subject to conditions, and the company continues to face significant risks including insufficient share capital and Nasdaq compliance requirements.

• · SEC investigation concluded with no penalties.
• · Founding team has fully returned to the company.
• · The $25M convertible notes are unregistered and subject to trading restrictions.
• · Of the $25M, $12.5M is directly in the operating account; the remaining $12.5M is in controlled accounts with conditions for release.
• · The full strategic plan (upgraded from Ten-Punch Combo to Five Key Transformations) will be unveiled in YT's Investor Weekly Report on Sunday.
• · Key application scenarios: education, security inspection, reception and guided tours, performance, and university research.
• · Company expects to move EAI Vehicle business away from high-cost short-term funding toward operating cash flow, industry partnerships, and long-term capital.

18-05-2026

Flux Power Holdings, Inc. entered into a committed equity facility with Roth Principal Investments, LLC, allowing the company to sell up to $40,000,000 of common stock at its sole discretion over a 36-month period. The agreement includes multiple purchase mechanisms (Market Open, Intraday, Pre-Market, Post-Market) and conditions such as a minimum stock price threshold of $0.50 per share. This facility provides potential capital but may lead to dilution for existing shareholders.

• · The per share purchase price for all purchase types is calculated at a fixed 3.0% discount to the applicable VWAP.
• · The registration rights agreement covers up to 38,461,538 shares of common stock.
• · The facility includes a threshold price of $0.50 per share, below which no purchases can be initiated on that trading day.
• · The company may also conduct Intraday Purchases after 10:00 a.m. and before 2:00 p.m. New York City time on qualifying trading days.
• · Pre-Market Purchases are limited to a maximum of 1,000,000 shares and up to 20% of trading volume, with notices delivered between 7:00 a.m. and 8:30 a.m. New York City time.
• · The company has no obligation to sell any shares under the agreement.

18-05-2026

Context Therapeutics entered into an amendment to its exclusive license agreement with BioAtla for CT-202, its Nectin-4 x CD3 T cell engager. The amendment removes all future milestone and royalty obligations in exchange for a $4.5 million upfront payment and a second $2.0 million payment due by August 1, 2026, granting Context a fully paid-up, non-terminable license. The company expects to initiate a Phase 1 clinical trial for CT-202 in the third quarter of 2026.

• · CT-202 targets Nectin-4, a cell surface protein overexpressed in bladder, colorectal, lung, and breast cancers.
• · CT-202 is a pH-dependent TCE designed for preferential activity within the tumor microenvironment.
• · The clinical trial identifier for the Phase 1 study is NCT07545122.
• · Context's pipeline includes CTIM-76 (Claudin 6 x CD3 TCE) and CT-95 (Mesothelin x CD3 TCE).

18-05-2026

18-05-2026

LanzaTech Global, Inc. entered into a securities purchase agreement to sell 2,000,000 shares of common stock at $10.00 per share in a registered direct offering, generating gross proceeds of $20.0 million. Concurrently, the company amended its existing subscription agreement with LanzaTech Global SPV, LLC, lowering the cash balance threshold for additional share purchases from $40 million to $30 million. Net proceeds from the offering will be used for general corporate purposes.

• · The offering was conducted under an effective shelf registration statement on Form S-3 (File No. 333-279239).
• · Closing of the offering is expected on May 18, 2026.
• · The PIPE subscription amendment also provided that LT Global consented to the offering in connection with its consent rights over future financings.
• · The Company has until May 13, 2027, to require LT Global to purchase up to an additional $20.0 million of shares, subject to the lowered cash requirement of $30 million.

18-05-2026

Gossamer Bio, Inc. filed an 8-K on May 18, 2026, reporting multiple material events including entry into a definitive agreement (Item 1.01), results of operations (Item 2.02), officer changes (Item 5.02), Regulation FD disclosure (Item 7.01), and other events (Item 8.01). However, the filing content is not provided in the query, so specific financial metrics, transaction details, and officer names are unavailable. The filing is multi-item and likely mandatory due to the inclusion of financial results. Without actual data, a directional assessment is not possible.

18-05-2026

AstroNova, Inc. entered into a settlement agreement on May 15, 2026, resolving all claims related to the May 2024 acquisition of MTEX New Solution by AstroNova Portugal. Key terms include the transfer of an industrial property in Porto, Portugal (valued at €2.5 million) to AstroNova Portugal, waiver of lease amounts owed by MTEX, and release of personal guarantees by Mr. Ferreira. Pending arbitration proceedings in Portugal will be terminated upon property registration. The settlement removes legal uncertainties and provides AstroNova with a tangible asset without additional cash outlay.

• · The settlement includes a mutual release of all claims between the parties
• · Atlantiprestigio will waive its right to receive any amounts from MTEX under the lease agreement for the property
• · AstroNova and AstroNova Portugal agreed to cause Mr. Ferreira and his spouse to be released from certain personal guarantees for loans extended to MTEX
• · Pending arbitration proceedings in the Arbitration Center in Oporto, Portugal will be terminated upon definitive registration of the property
• · The settlement also addresses allocation of arbitration costs

18-05-2026

18-05-2026

Akamai Technologies proposes to offer $2.6 billion aggregate principal amount of 0% convertible senior notes in two tranches ($1.3 billion due 2030 and $1.3 billion due 2032), with an option for initial purchasers to buy an additional $400 million. Proceeds will fund accelerated capital expenditures for the Cloud Infrastructure Services (CIS) business and a $350 million share repurchase, partially offset by costs of convertible note hedge transactions. The notes carry no regular interest and are unsecured; dilution from conversion will be hedged, but warrant transactions could cause future dilution if the stock exceeds the strike price.

• · The notes are offered only to qualified institutional buyers under Rule 144A and are not registered under the Securities Act.
• · Notes are senior unsecured obligations; no regular interest accrues, only special interest if triggered.
• · Conversion settlement is cash up to principal amount; excess conversion value may be settled in cash, shares, or a combination at Akamai's election.
• · Option Counterparties are expected to enter into share and derivative transactions that could affect Akamai's stock price at pricing and during the life of the notes.
• · If a fundamental change occurs, holders can require repurchase at 100% of principal plus accrued special interest.
• · The offering is subject to market conditions and there is no assurance of completion.

18-05-2026

Clear Channel Outdoor Holdings, Inc. entered into a Third Amendment to its ABL Credit Agreement on May 15, 2026, to facilitate its planned merger under a February 9, 2026 Merger Agreement. The amendment extends the maturity date of revolving credit commitments for consenting lenders and adds $50,000,000 in incremental revolving commitments, bringing total revolving commitments to $250,000,000. The company also agreed to reduce its Term/Revolver Credit Agreement commitments to $0 and pay consent fees of 0.20% on existing commitments and 0.30% on incremental commitments.

• · The amendment is conditioned on the closing of the merger under the Agreement and Plan of Merger dated February 9, 2026.
• · Conditions to effectiveness include receipt of legal opinion from Freshfields US LLP, a solvency certificate, and certification of no Default or Event of Default.
• · The Term/Revolver Credit Agreement commitments will be reduced to $0 substantially concurrently with the Third Amendment Effective Date.
• · Consent fees are payable on or prior to the Merger Agreement Closing Date, and only if the closing occurs.
• · The Administrative Agent may require adjustments to participations in Letters of Credit and Swingline Loans to ensure pro-rata allocation among all Lenders after the incremental increase.

18-05-2026

Old Republic International Corporation priced a $700 million registered public offering of 5.700% Senior Notes due 2036 on May 13, 2026, with Morgan Stanley and PNC Capital Markets as representatives. The notes mature June 1, 2036, bear interest semi-annually, and are issued under an indenture with Wilmington Trust Company. This financing creates a direct financial obligation and includes customary redemption provisions.

• · Underwriting Agreement dated May 13, 2026, with representatives Morgan Stanley and PNC Capital Markets.
• · Base Indenture dated August 15, 1992, supplemented by Ninth Supplemental Indenture dated May 18, 2026.
• · Interest payment dates: June 1 and December 1, starting December 1, 2026.
• · Par Call Date is March 1, 2036 (3 months prior to maturity). Prior to that date, redemption price is greater of 100% of principal or present value at Treasury Rate plus 20 bps; on/after Par Call Date, redemption at 100% of principal plus accrued interest.
• · Registration statement on Form S-3 (No. 333-277713) filed March 6, 2024.
• · Prospectus supplements filed May 13, 2026 (preliminary and final).

18-05-2026

Babcock & Wilcox Enterprises announced the pricing of an underwritten public offering of 10,810,811 shares of common stock at $18.50 per share, with gross proceeds of approximately $200 million. The net proceeds will be used to prepay and reborrow under its Credit Agreement to fund project-related capital, working capital, growth initiatives including AI data center power generation and BrightLoop technology commercialization, potential acquisitions, and balance sheet strengthening. The offering, led by B. Riley Securities, is expected to close on May 18, 2026, but will dilute existing shareholders may face dilution from the new shares and the underwriters' 30-day option to purchase an additional 15%.

• · The offering is being made under a shelf registration statement effective April 8, 2025.
• · Underwriters have a 30-day option to purchase up to an additional 15% of the shares at the public offering price less discounts.
• · B. Riley Securities is the lead book-running manager; Craig-Hallum and Lake Street Capital Markets are joint book-running managers; Northland Capital Markets is co-manager.
• · The offering is expected to close on May 18, 2026.
• · Use of proceeds includes prepaying Credit Agreement amounts and reborrowing to fund project-related capital and working capital needs for steam turbine and boiler production capacity.

18-05-2026

Arrive AI Inc. entered into a Standstill Agreement with investor Streeterville Capital, LLC on May 14, 2026, restricting the investor from delivering Purchase Notices under outstanding Pre-Paid Purchases from May 14, 2026 to December 31, 2026, unless the company's stock trades at a price at least 15% above the Nasdaq Minimum Price. No additional cash or property was exchanged. The standstill terminates upon material breach or default by the Company.

• · Investor may submit purchase notices during the standstill period on any trading day where the stock price is at least 15% greater than the Nasdaq Minimum Price under Rule 5635(d).
• · The standstill period runs from May 14, 2026 to December 31, 2026.
• · No additional cash or other property consideration was exchanged for the Standstill Agreement.
• · Outstanding pre-paid purchases remain in full force and effect except for the delivery restriction during the standstill.

18-05-2026

Advanced Energy Industries Inc. entered into a call option transaction (convertible note hedge) with a dealer as part of its offering of Convertible Senior Notes due 2031. The hedge is intended to reduce potential dilution from conversion of the notes, using a Modified American call option structure under an ISDA Master Agreement. Many specific terms (e.g., strike price, premium, number of options) were left as placeholders in the filing, indicating a draft template or that final amounts were not disclosed.

• · The call option is subject to an ISDA 2002 Master Agreement with the laws of New York as governing law.
• · The option is styled as 'Modified American' and can be automatically exercised on conversion dates after the Free Convertibility Date (February 15, 2031).
• · The transaction includes provisions for automatic exercise of remaining repurchase options before the Expiration Date (May 15, 2031).
• · The Shares are AEIS common stock (par value $0.001 per share) listed on the Nasdaq Global Select Market.
• · The confirmation references both a Base Call Option and an Additional Call Option (greenshoe), but the filing does not specify which this covers.

18-05-2026

Blue Bird Corporation's subsidiary entered into an agreement with Pacific Life to transfer pension obligations for 2,044 participants via group annuity contracts, settling approximately $94 million in remaining Plan liabilities as of April end 2026. The company also completed $13 million in lump-sum distributions in April 2026. While this de-risks the pension plan, it expects a material non-cash pension settlement charge in its third fiscal quarter ending June 27, 2026. The transactions are funded entirely by Plan assets with no additional company funding required.

• · The Plan is a frozen defined benefit pension plan qualified under the Internal Revenue Code.
• · The premium paid to Pacific Life is confidential but less than the total current amount of Plan assets.
• · The transaction is expected to close on May 19, 2026, with Pacific Life assuming liability as of August 1, 2026.
• · The material non-cash pension settlement charge will be recognized during the third fiscal quarter ending June 27, 2026, pending final actuarial remeasurement.
• · Cash remaining in the Plan after the annuity purchase will be disbursed through end of 2026 for retiree payments and termination expenses.

18-05-2026

Zevia PBC's subsidiary, Zevia LLC, amended its Secured Revolving Line of Credit with Bank of America, extending the maturity date to February 22, 2030, and reducing the credit spread adjustment on the Term SOFR margin to 0.10%. The amendment also revised financial covenants, including a minimum liquidity requirement of $7,000,000 until the fixed charge coverage ratio reaches 1.00x for two consecutive quarters.

• · The First Amendment was entered on May 15, 2026, and reported on May 18, 2026.
• · Maturity date extended from original 2022 agreement to February 22, 2030.
• · Fixed charge coverage ratio covenant of 1.00 to 1.00 applies if availability drops below $3 million or 17.5% of borrowing base, or upon certain events of default.

18-05-2026

On May 18, 2026, PPL Corp's wholly owned subsidiary, The Narragansett Electric Company (d/b/a Rhode Island Energy), issued $400 million aggregate principal amount of 6.000% Senior Notes due 2056 in a private placement. Net proceeds of $396.3 million after discounts and commissions will be used to repay short-term debt incurred primarily for capital expenditures and general corporate purposes. The notes are unsecured senior obligations of the issuer and are not guaranteed by PPL Corporation or its other subsidiaries.

• · The Notes were issued under a Base Indenture dated March 22, 2010, as supplemented by a Seventh Supplemental Indenture dated May 18, 2026.
• · Interest is payable semiannually on May 15 and November 15, beginning November 15, 2026.
• · The Notes mature on May 15, 2056, subject to early redemption at the issuer's option.
• · The Notes are unsecured senior obligations ranking pari passu with existing and future unsecured senior indebtedness and senior to subordinated indebtedness; they are effectively subordinated to secured indebtedness.
• · The Indenture contains no restrictive covenants except those restricting mergers, consolidations, or asset sales.

18-05-2026

Duke Robotics Corp. priced an underwritten public offering of 1,125,000 units at $8.20 per unit, expecting gross proceeds of approximately $9.2 million. Each unit consists of one share of common stock and one warrant (exercise price $8.60, 5-year term). The company also uplisted to the Nasdaq Capital Market, with shares and warrants trading under symbols DUKR and DUKRW, respectively. Proceeds will be used for R&D, sales force expansion, marketing, business development, potential acquisitions, and working capital. The offering is expected to close on May 18, 2026.

• · The offering includes a 45-day over-allotment option for up to 168,750 additional shares and/or warrants.
• · Maxim Group LLC is acting as sole book-running manager.
• · The registration statement on Form S-1 (File No. 333-294808) was declared effective on May 14, 2026.
• · Trading on Nasdaq Capital Market expected to begin May 15, 2026 under symbols DUKR (common stock) and DUKRW (warrants).
• · The company has a collaboration agreement with Elbit Systems Land Ltd. for the Bird of Prey weapons drone system.

18-05-2026

DevvStream Corp. reported the automatic termination of its Prior Merger Agreement with Southern Energy Renewables Inc. following the expiration of Fairness Opinion Termination Rights under the new Business Combination Agreement (BCA) with XCF Global Inc. The termination occurred without any liability to the parties. The BCA transaction remains subject to customary closing conditions and forward-looking milestones including annualized revenue targets.

• · The Prior Merger Agreement was automatically terminated without liability upon expiration of the Fairness Opinion Termination Rights as agreed by the parties.
• · The BCA with XCF Global involves DevvStream becoming a wholly-owned subsidiary of XCF after closing.
• · The BCA is binding but subject to customary closing conditions, including regulatory and stockholder approvals.
• · Forward-looking targets include $1.0B in annualized revenue, $100M minimum annualized EBITDA, and a $3.0B combined enterprise value.
• · Southern Energy Renewables may receive authorization to issue up to $400M in state-supported bonds.
• · No financial results or period-over-period comparisons are provided in this filing.

18-05-2026

26North BDC, Inc. entered into Amendment No. 2 to its Loan and Security Agreement with JPMorgan Chase Bank, N.A., increasing the total commitment from the lender to $650,000,000. The amendment became effective May 13, 2026, and included an upfront fee of $187,397.26 payable to JPMorgan. No negative or flat metrics are present; this is a straightforward positive event expanding the company's borrowing capacity.

• · Amendment No. 2 was executed on May 13, 2026, and effective that same date.
• · Original agreement was dated February 7, 2025, and previously amended by Amendment No. 1 on September 5, 2025.
• · The commitment increase is to $650,000,000 total from the Second Amendment Effective Date to the Maturity Date.
• · The upfront fee of $187,397.26 is non-refundable.
• · Conditions to effectiveness included execution, payment of fees, representations and warranties, delivery of corporate documents and legal opinions.
• · The loan is governed by New York law.
• · No Default or Event of Default existed before or after giving effect to the amendment.

18-05-2026

Wayfair Inc. subsidiary Wayfair LLC issued $400 million aggregate principal amount of 7.125% senior secured notes due 2034, using net proceeds to repay a portion of existing indebtedness and for general corporate purposes. Concurrently, Wayfair called for redemption all outstanding 3.50% Convertible Senior Notes due 2028, with a redemption date of June 29, 2026; holders may convert before that date at an increased conversion rate of 23.3162 shares per $1,000 principal (vs. standard 21.8341). The high coupon on the new notes (7.125%) reflects increased debt costs, while the redemption of lower-coupon convertible notes (3.50%) reduces near-term maturity risk but may cause dilution if holders convert.

• · Interest on new notes payable semi-annually on May 15 and November 15, beginning November 15, 2026, until maturity May 31, 2034.
• · The indenture contains restrictive covenants including limitations on additional indebtedness, dividends, investments, liens, affiliate transactions, asset sales, and mergers, subject to exceptions and a 'fall-away' clause if notes achieve investment grade ratings from any two prescribed rating agencies.
• · Redemption of 2028 Notes scheduled for June 29, 2026; holders must convert by the second scheduled trading day before that date to benefit from the increased conversion rate.
• · If converted, 2028 Notes will be settled in cash up to principal amount and shares of Class A common stock for the excess, plus cash for fractional shares.
• · Wayfair may offer to repurchase notes at 101% of principal upon a change of control, and may be required to offer to purchase notes under certain asset sale circumstances.
• · The new notes and guarantees are unregistered and offered only to QIBs (Rule 144A) and non-U.S. persons (Regulation S).

18-05-2026

Knife River Corporation entered into a Second Amendment to its Credit Agreement, refinancing $495 million of existing term loans with new 2026 Repricing Tranche B Term Loans and adding $400 million in 2026 Incremental Term Loans, for total new term loans of $895 million. The proceeds are used to repay outstanding existing term loans, pay accrued interest and fees, and for working capital and general corporate purposes. The transaction closed on May 15, 2026, with JPMorgan Chase Bank as Administrative Agent and Bank of America as lead left arranger.

• · The amendment refinances all outstanding Initial Tranche B Term Loans with new 2026 Repricing Tranche B Term Loans of $495M, using a cashless roll mechanism for consenting lenders.
• · An additional $400M in 2026 Incremental Term Loans is provided by new lenders, forming a fungible increase to the same tranche.
• · Proceeds of the incremental loans are for working capital, general corporate purposes, permitted investments, and repayment of revolving loans.
• · Conditions to effectiveness include no Material Adverse Effect since December 31, 2025, and delivery of solvency certificate, legal opinions, and KYC documentation.
• · The amendment modifies certain provisions of the original Credit Agreement provisions (stricken and double-underlined text referenced in Exhibit A).

18-05-2026

Ichor Holdings entered into a Sales Agreement with TD Securities, Stifel, Needham & Company, and Craig-Hallum Capital Group to sell up to $200,000,000 of its ordinary shares in at-the-market offerings. Net proceeds will be used to repay outstanding indebtedness under its term loan facility and for general corporate purposes, including capital expenditures and potential acquisitions. The filing includes legal opinions from Maples and Calder (Cayman) LLP.

• · The offering is made under a shelf registration statement on Form S-3ASR (File No. 333-295995) filed and effective on May 18, 2026.
• · The Company has no obligation to sell any shares under the Sales Agreement and may suspend the offering at any time.
• · The Sales Agreement may be terminated by either party upon written notice, and automatically terminates upon sale of all shares subject to the agreement.

18-05-2026

Star Equity Holdings, Inc. entered into an At Market Issuance Sales Agreement with Ladenburg Thalmann & Co. Inc. to sell up to $8,700,000 of its 10% Series A Cumulative Perpetual Preferred Stock. The company is not obligated to sell any shares and may suspend offerings at any time; the sales agent receives a 3.0% commission. The agreement provides a flexible capital-raising mechanism but does not guarantee any issuance.

• · The Sales Agreement was entered into on May 18, 2026.
• · The offering is made under a previously filed S-3 registration statement (File No. 333-294548) declared effective on April 1, 2026.
• · A prospectus supplement was filed on May 18, 2026.
• · Sales may be made at market prices, including on the Nasdaq Global Select Market, in block transactions, or by other lawful methods.
• · The company will reimburse the Sales Agent for certain specified expenses.
• · Exhibits filed include the Sales Agreement (Exhibit 1.1) and a legal opinion from Baker & Hostetler LLP (Exhibit 5.1).

18-05-2026

APi Group closed previously announced financing transactions: a $500M private offering of 5.75% senior notes due 2034, and an amendment extending its Term Loan B to 2033 and upsizing its revolving credit facility to $1.0B (maturing 2031). While these actions improve liquidity and extend debt maturities, they also increase the company's overall leverage and interest expense.

• · The senior notes were offered under Rule 144A and Regulation S (private placement).
• · The amendment extends the Term Loan B maturity to 2033 and the revolving credit facility maturity to 2031.
• · The revolving credit facility was upsized from an undisclosed prior amount to $1.0B.
• · APi Group has over 500 locations worldwide and provides fire & life safety, security, elevator/escalator, and specialty services.

18-05-2026

Palatin Technologies, Inc. (PTN) announced on May 18, 2026 its voluntary withdrawal from the NYSE American and transfer of its common stock listing to the Nasdaq Capital Market, effective May 29, 2026. The Nasdaq has approved the listing, and the stock will continue trading under the same symbol 'PTN'. NYSE trading will cease at the close on May 28, 2026. No financial impact or performance metrics were disclosed.

• · The voluntary delisting was authorized by the Board of Directors.
• · The transfer to Nasdaq was approved by Nasdaq before the filing.
• · Trading symbol remains PTN.
• · NYSE American trading ceases at close on May 28, 2026.
• · Nasdaq trading begins on May 29, 2026.

18-05-2026

Silence Therapeutics plc entered a new Open Market Sale Agreement with Jefferies LLC to sell American Depositary Shares (ADSs) up to an unspecified maximum program amount, replacing the prior agreement from October 2021. The company also updated its PFIC classification, now believing it was not a PFIC for the taxable year ended December 31, 2025, thereby reducing adverse U.S. tax concerns for U.S. holders, though no assurance is given for future years.

• · The Sales Agreement replaces the prior Open Market Sale Agreement dated October 15, 2021, which was terminated as of May 18, 2026.
• · The ADSs will be issued pursuant to the shelf registration statement on Form S-3 (File No. 333-295992) filed on May 18, 2026.
• · Legal opinion on ADS validity from Cooley (UK) LLP filed as Exhibit 5.1.
• · The company performed further tax analysis and now believes it was not a PFIC for the taxable year ended December 31, 2025, although its U.S. counsel expressed no opinion on PFIC status for any taxable year.

18-05-2026

Netcapital Inc. entered into a Securities Purchase Agreement with LABRYS FUND II, L.P. on May 12, 2026, for the sale of securities (likely a convertible note). Proceeds are to be used for business development and general working capital. The agreement includes customary representations, warranties, and restrictive covenants, including limitations on changing business nature or selling material assets until the note is paid or converted.

• · The agreement restricts the company from changing its business nature or selling material assets without buyer consent until the note is paid or converted.
• · The company must maintain the listing of its securities as long as the buyer holds any securities.
• · The company filed a Form D with respect to the securities (if required under Regulation D) and will comply with blue sky laws.
• · Environmental compliance, title to property, internal controls, and foreign corrupt practices representations are included.

18-05-2026

Cartesian Growth Corporation III entered into a $150,000 promissory note payable to its sponsor, CGC III Sponsor LLC, on May 18, 2026. The note carries no interest and matures upon the earlier of an initial business combination or winding up. It may be converted into working capital warrants at $1.00 per warrant, with terms matching the sponsor's private placement warrants from the May 2025 IPO.

• · The promissory note is non-interest bearing and payable upon the consummation of an initial business combination or the winding up of the issuer.
• · At the sponsor's option, the principal can be converted into working capital warrants at a conversion price of $1.00 per warrant, with the same terms as the private placement warrants from the IPO.
• · The payee (sponsor) has waived any claim against the trust account, but principal will be repaid from trust proceeds upon business combination.
• · The note is unsecured and no personal liability attaches to officers, directors, or shareholders.

18-05-2026

Sonida Senior Living, Inc. (SNDA) entered into an Equity Distribution Agreement on May 18, 2026, establishing an at-the-market (ATM) equity program with a maximum aggregate gross offering price of up to $250,000,000. The Company intends to use net proceeds for potential acquisitions, capital expenditures, working capital, and general corporate purposes including debt repayment. While the program provides substantial financial flexibility to fund growth, any equity sales will result in shareholder dilution, and the forward sale structure allows the Company to potentially defer dilution but carries the risk that the Company may receive no proceeds or owe cash or shares under certain settlement scenarios.

• · Sales under the ATM Program may be executed on the NYSE, in block trades, or through other negotiated transactions at market prices.
• · The program utilizes a forward sale structure alongside direct sales, allowing the Company to potentially defer both receipt of proceeds and corresponding dilution.
• · Under the forward sale structure, the Company will not initially receive any proceeds. It expects to physically settle by delivering shares, but may also choose cash or net share settlement, in which case it could receive no proceeds and may owe cash or shares to the forward purchaser.
• · The shelf registration statement supporting this ATM program was initially filed on July 30, 2024.
• · The Distribution Agreement terminates upon the earlier of the sale of all shares subject to the program or agreement termination by the parties.

18-05-2026

Ondas Holdings Inc. has entered into a definitive agreement to acquire 100% of Omnisys Ltd., an Israeli developer of AI-powered Battle Resource Optimization (BRO) software for multi-mission defense planning. The acquisition adds a combat-proven, revenue-generating AI software platform and establishes BRO as a central mission optimization layer across Ondas' autonomous systems, transitioning Ondas to a full systems-of-systems orchestrator. Omnisys has a history of profitable operations without reliance on external capital, but no financial terms of the acquisition were disclosed in the filing.

• · Omnisys' BRO platform integrates data from multiple sensors, platforms, and C2 systems using advanced AI and operations research to generate optimized courses of action in real time.
• · BRO supports the full operational cycle: pre-mission planning, in-mission dynamic adaptation, and post-mission debriefing.
• · Omnisys has a global customer base spanning NATO and allied defense organizations.
• · The acquisition will integrate BRO with Ondas' SkyWeaver platform for AI-driven battlefield coordination and real-time resource optimization.
• · BRO is vendor-agnostic and can integrate with US defense systems across multi-domain operations (space, air, sea, land, spectrum).

18-05-2026

CoreWeave closed a $3.1 billion delayed draw term loan facility (DDTL 5.0), the first publicly syndicated HPC-backed financing, which was meaningfully oversubscribed and saw pricing tighten by 50 basis points to SOFR + 4.50%. The facility, rated Ba2/BB+, supports deployments under two customer contracts and matures in ~5.5 years, further validating AI infrastructure as an asset class while the company has secured over $20 billion in debt and equity capital year-to-date. Despite the strong demand and institutional validation, the facility is rated below investment grade and tied to specific non-investment grade customers, introducing concentration risk.

• · The DDTL 5.0 has a maturity of approximately 5.5 years and is issued through CoreWeave Financing DDTL V, LLC.
• · The facility is a delayed draw term loan designed to align funding with deployment schedule and useful life of GPU assets.
• · Proceeds support two large, non-investment grade customer contracts.
• · Morgan Stanley and MUFG served as joint lead arrangers and bookrunners.
• · CoreWeave completed its public listing on Nasdaq (CRWV) in March 2025.
• · The DDTL 4.0 facility was investment-grade rated (not specified which rating) and was $8.5 billion.

18-05-2026

Phunware appointed Dmitry Kroshka as CEO to lead its 2.0 Strategy and engaged Michael Cerdá's Build Something Product Group (BSPG) for product strategy and rollout. The company reports AI Concierge engagement running 40% above internal forecasts, sustained customer retention above 95%, and a strong cash position with no debt, positioning it for next-phase growth across hospitality, healthcare, and large-property verticals.

• · Dmitry Kroshka has over 20 years of experience including roles at Oracle, FOX Digital Entertainment, and Spark Brands, and has served as a senior advisor to Phunware since October 2025.
• · Michael Cerdá previously led product at Disney+, Marcus by Goldman Sachs (Apple Card), and Facebook Newsfeed.
• · Phunware reported Q1 2026 results on May 7, 2026, prior to this announcement.
• · The company has no debt and capital flexibility to invest in R&D, intellectual property, and organic/inorganic growth.
• · Management expects to host an investor webinar in investor webinar in the coming weeks and will exhibit AI Concierge at HITEC North America 2026.
• · The Guest Intelligence Platform is intended to extend into healthcare campuses and other large-scale enterprise property environments.

18-05-2026

Dominion Energy filed an 8-K on May 18, 2026, covering Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). The filing size (22 MB) suggests significant exhibits, but the specific terms, counterparties, and financial impact are not disclosed in the provided metadata. Without the filing text, no positive or negative metrics can be extracted.

• · Filing date: May 18, 2026
• · Filing size: 22 MB (suggests extensive exhibits)
• · Multi-item filing: Items 1.01, 7.01, and 9.01

18-05-2026

Boston Omaha Corporation (BOC) announced it has signed a definitive agreement to sell its surety insurance business (General Indemnity Group, GIG) to CopperPoint Insurance Company for all cash. The transaction, subject to regulatory approvals and closing conditions, is expected to close by year-end 2026. For FY2025, GIG reported total revenues of $27.2 million. Proceeds will be held as cash and cash equivalents for future investments, including potential share repurchases.

• · Transaction is structured as an all-cash sale of all outstanding equity interests of GIG.
• · CopperPoint Insurance Company is rated A (Excellent) by AM Best and is based in Phoenix, Arizona.
• · Boston Omaha acquired UCS in 2016, when it was licensed only in Massachusetts and a few eastern states; it is now licensed in all 50 states and DC.
• · Proceeds may be used for new investments, existing business interests, and/or share repurchases.
• · The filing includes forward-looking statements and a copy of the Securities Purchase Agreement.

18-05-2026

Inotiv, Inc. entered into a Ninth Amendment to its Credit Agreement on May 14, 2026, establishing a $40 million Bridge Facility Delayed Draw Term Loan and terminating all revolving commitments, which were repaid in full from the facility's proceeds. Lenders also waived a specified default resulting from the company's failure to pay principal or interest on Permitted Convertible Indebtedness on April 16, 2026, with the waiver extending through June 3, 2026. The amendment carries significant costs—a 2.50% PIK consent fee for existing term lenders and a 1.00% PIK closing fee for bridge lenders—underscoring the company's liquidity challenges and reliance on lender support.

• · The waived default relates to a failure to pay principal or interest on Permitted Convertible Indebtedness due April 16, 2026.
• · The waiver is effective only through June 3, 2026 and does not waive any other defaults.
• · Revolving Loans (including the Third Amendment RCF Deferred Fee) were fully repaid from the Bridge Facility proceeds on the Ninth Amendment Effective Date.
• · The Bridge Facility is a delayed draw term loan, not a revolver.
• · Existing Term Lenders received a PIK Consent Fee of 2.50% of their outstanding Term Loans, capitalized into principal.
• · Bridge Facility Lenders received a 1.00% PIK closing fee, also capitalized.
• · Precisium Solutions, LLC executed a joinder agreement as a new Loan Party.

18-05-2026

RideNow Group, Inc. received conditional approval from Polaris Acceptance to increase its credit facility from $74.65 million to $108 million. The activation requires execution of amended agreements and proof of property insurance within 30 days, and is subject to no material adverse change. If conditions are not met, the facility remains at the original $74.65 million.

• · The increase requires an Amended and Restated Guaranty from six specific entities: RideNow Group, Inc., North County 355 Holdings,Inc., Georgetown 355 Holdings, Inc., Fun Center Holdings, Inc., CMG Powersports, Inc., and America’s Powersports, Inc.
• · Property insurance must cover the maximum aggregate credit facility ($108M) and evidence must be provided.
• · The condition deadline is 30 days from April 15, 2026 (the letter date), and any material adverse change could void the increase.
• · The credit facility is for inventory financing from Polaris Acceptance, a Wells Fargo entity.

18-05-2026

Ligand Pharmaceuticals filed an 8-K reporting Amendment No. 1 to the Agreement and Plan of Merger with XOMA Royalty Corporation. The amendment adds XOMA Royalty Holdings Corporation as a party and makes minor technical revisions to sections of the merger agreement. No financial terms or changes to deal economics were disclosed, and the transaction appears to be proceeding on the previously announced terms.

• · The amendment was executed on May 16, 2026, reflecting a quick turnaround from the original April 27, 2026 merger agreement.
• · HoldCo was formed on May 15, 2026, specifically to facilitate the transactions contemplated in the merger.
• · Specific amendments include expanding the statutory reference in Section 1.1(b) to the entire NRS 92A, and correcting references in Sections 1.5 and 5.23 from 'Company'/'Surviving Company' to 'Surviving Corporation'.

18-05-2026

On May 15, 2026, Synergy CHC Corp. received a Nasdaq notice for failure to maintain the minimum $1. bid price of $1.00 per share over 30 consecutive business days. The company has 180 calendar days, until November 11, 2026, to regain compliance by having the closing bid price at $1.00 or higher for at least 10 consecutive business days. The company is evaluating options including a potential reverse stock split, but there is no guarantee of regaining compliance.

• · The notice was received on May 15, 2026.
• · The company has until November 11, 2026 (180 calendar days) to regain compliance.
• · To regain compliance, the stock must close at or above $1.00 per share for at least 10 consecutive business days.
• · If compliance is not regained by November 11, 2026, the company may be eligible for an additional 180-day period if it meets all other initial listing standards except the bid price requirement and provides notice of intent to cure via a reverse stock split.
• · The company trades on The Nasdaq Capital Market under the symbol SNYR.
• · The company's common stock has a par value of $0.00001 per share.

18-05-2026

XOMA Royalty Corp (XOMAP) filed an 8-K on May 18, 2026, disclosing Amendment No. 1 to its Agreement and Plan of Merger with Ligand Pharmaceuticals Incorporated. The amendment adds XOMA Royalty Holdings Corporation (HoldCo) as a party to the merger agreement and makes minor technical corrections to statutory references and replacements of certain references. HoldCo was formed on May 15, 2026, to facilitate the merger transactions. This filing provides no financial figures or updated terms; it is a procedural step in the previously announced acquisition.